Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic t | DDDT
The D816V mutation in the catalytic domain of the c-Kit receptor downstream tyrosine kinase in peripheral blood mononuclear cells (by M. Niedoszytko).
The major topics of the research work of Prof. Stefan Seregard: vision-research.eu - The Gateway to European Vision Research
Main pathways activated by the tyrosine-kinase receptor c-KIT and its... | Download Scientific Diagram
IJMS | Free Full-Text | Possible Prognostic and Therapeutic Significance of c-Kit Expression, Mast Cell Count and Microvessel Density in Renal Cell Carcinoma